![Mark Jason H. Ellison](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mark Jason H. Ellison
Directeur/Membre du Conseil chez
Phax Pharma Consultants
Profil
Mark Jason H.
Ellison is currently the Director at Phax Pharma Consultants and a Member at GPhC.
He was previously the Chief Development Officer at Opiant Pharmaceuticals, Inc. from 2020 to 2023 and the Head-Technical Affairs at S.L.A. Pharma AG from 2010 to 2014.
Ellison holds a doctorate degree from the University of Sunderland and an undergraduate degree from the University of Portsmouth.
Postes actifs de Mark Jason H. Ellison
| Sociétés | Poste | Début |
|---|---|---|
GPhC | Corporate Officer/Principal | - |
Phax Pharma Consultants | Directeur/Membre du Conseil | - |
Anciens postes connus de Mark Jason H. Ellison
| Sociétés | Poste | Fin |
|---|---|---|
| OPIANT PHARMACEUTICALS, INC. | Corporate Officer/Principal | 02/03/2023 |
S.L.A. Pharma AG
 S.L.A. Pharma AG BiotechnologyHealth Technology Operates as a biopharmaceutical company | Directeur Technique/Scientifique/R&D | 01/01/2014 |
Formation de Mark Jason H. Ellison
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
12
Relations au 1er degré
6
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Opiant Pharmaceuticals, Inc.
 Opiant Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops medicines for addictions and drug overdose | Health Technology |
University of Sunderland
 University of Sunderland Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Portsmouth
 University of Portsmouth Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
S.L.A. Pharma AG
S.L.A. Pharma AG BiotechnologyHealth Technology Operates as a biopharmaceutical company | Health Technology |
GPhC | |
Phax Pharma Consultants |
